Our Latest News

Stay tuned with Golden Helix Foundation

We are delighted to announce that the Golden Helix Foundation has entered an agreement with the University of Malaya to become the Regional Center of the Golden Helix Foundation in Asia-Pacific. The two entities have signed a Memorandum of Understanding for joint research and educational activities, focusing in particular on Public Health Genomics.

The first joint project will be announced in April 2016 and will be implemented in the region of Southeast Asia.

We are excited to report that the U-PGx proposal that was submitted in the PHC-24-2015 Piloting personalised medicine in health and care systems H2020 call has been favourably evaluated by the European Commission in stage 2 evaluations and achieved top score. The project will have a funding volume of 14,9 million Euros and a duration of 60 months. The grant agreement is expected to be finalised within the next 3 months.

The Golden Helix Foundation participates in the U-PGx project as full partner and Component Leader (Project coordinator: Prof. Henk-Jan Guchelaar; Leiden University Medical Center, the Netherlands), responsible for the economic evaluation and dissemination activities.

Workshop: 16th Golden Helix Pharmacogenomics Day at Festival of Genomics Boston in June 22nd 2015 at 16:00-19:00

The 16th Golden Helix Pharmacogenomics Day is an educational event that aims to provide timely updates on the field of pharmacogenomics and personalized medicine to the local biomedical scientists and healthcare providers, to inform them on the application of pharmacogenomics in fields such as psychiatric disorders, oncology, and to bring together faculty members from universities and research institutes from the local scientific arena working in the field of pharmacogenomics in order to initiate collaborative projects in this field to the benefit of society.

This workshop will include:

  • Lectures by 6 speakers from the US, both from academia, industry and regulatory (NIH) backgrounds.
  • Topics will pertain to pharmacogenomics and personalized medicine
  • The Global Genomic Medicine Collaborative and the Genomic Medicine Alliance initiatives will be highlighted.

What will participants take away from this workshop?

  • The most recent trends on pharmacogenomics
  • The aims and goals of the Global Genomic Medicine Collaborative and the Genomic Medicine Alliance Initiatives
  • Collaboration and training opportunities with the faculty of the workshop

Organizing committee

George P. Patrinos, University of Patras Department of Pharmacy, Patras, Greece

Konstantinos Mitropoulos, the Golden Helix Foundation, London, UK

Speakers:

  • Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
  • Federico Innocenti, Associate Professor, University of North Carolina, Chapel Hill, NC, USA
  • Alan R. Shuldiner, Vice President, Translational Genetics, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
  • Marc S. Williams, Director, Genomic Medicine Institute, Geisinger Health System, Danville, PA,USA
  • George P. Patrinos, Associate Professor, University of Patras Department of Pharmacy, Patras, Greece
  • Deepak Voora, Assistant Professor, Duke Center for Genomic and Computational Biology, Durham, NC, USA

Enter promo code: Helix25 and get 25% off at registration.

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learning activities.

The Section of Pharmacogenomics and Pharmacogenetics is a formal section of IUPHAR, a non-profit association representing the interests of pharmacologists throughout the world and whose mission is: Better Medicines through Global Education and Research. The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug-related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical pharmacogenomics.

In furtherance of their mutual interest in improving fundamental and clinical pharmacogenomics and its translation into clinical practice, the two organizations have agreed: (a) cooperate and collaborate on programs and activities of mutual interest, (b) work together to provide education symposia/workshops in developing countries and regions, and (c) foster collaborative research to better understand the genetic basis for ethnic diversity in the response to and adverse effects from medicines. Also, from time to time, the organizations may cooperate in providing speakers, programs and supports for each others meetings.

The cooperation between these international organizations and the closely related to the Golden Helix Foundation Genomic Medicine Alliance, are expected to catalyze their invovlement in research and educational activities in the field of Genomic Medicine.

The 2014 Golden Helix Symposium was co-organized in Belgrade Serbia, October 30th - November 1st, 2014, by the Golden Helix Foundation, jointly with the Institute of Molecular Genetics and Genetic Engineering. This international conference marked the official launch of the Genomic Medicine Alliance and the 1stGenomic Medicine Alliance - Public Health Genomics Prize, awarded to the work of Chondrou and coworkers, entitled "Differential molecular profiling of human hematopoietic tissues during human ontogenesis: Implications for -type hemoglobinopathies therapeutics". This award is a joint initiative of Genomic Medicine Alliance and Karger, through its scientific journal Public Health Genomics, the Alliance's official journal.

This meeting was attended by over 250 registered speakers and participants from over 20 countries.

Next year, the Golden Helix Symposia travel to Asia, specifically in Kuala Lumpur, Malaysia for the forthcoming 2015 Golden Helix Symposium (March 11-13, 2015), which will mark the official partnership of the Genomic Medicine Alliance and the Southeast Asian Pharmacogenomics (SEAPharm) Consortium.

The 2014 Golden Helix Summer School was successfully organized in Apollo resort hotel in Aegina island, Greece, 11-15 September 2014. The meeting was attended by more than 80 registered participants from over 20 countries and attended lectures from internationally renowned speakers from Europe, the US, Middle East and Asia, including an EMBO lecture from Prof. Doug Higgs (Oxford, UK). Two trophies were presented to Ms. Marina Bartsakoulia (Newcastle, UK) and Prof. Sonja Pavlovic (Belgrade, Serbia) for submitting the two best abstracts for this meeting.

We believe that this meeting, co-organized by the Golden Helix Foundation and the Genomic Medicine Alliance, has set a high standard and we look forward to the co-oganization of the next Golden Helix Summer School in 2016. Please check back soon for more updates.

Page 2 of 4